| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 14, 2003
Accepted on March 24, 2004
From Baker Heart Research Institute (Wynn Domain) (B.O., B.A.K., A.H., L.S., P.N., D.S.), Melbourne, Victoria, Australia; and Daiichi Pure Chemicals (O.M.), Tokyo, Japan.
* To whom correspondence should be addressed. E-mail: Dmitri.Sviridov{at}Baker.edu.au.
Background--Physical exercise is associated with a decreased risk of cardiovascular disease, which may be partly caused by the effect of exercise on the lipoprotein profile. The most consistent effect of exercise on lipoprotein metabolism is an increase in high-density lipoprotein (HDL).
Methods and Results--Parameters of reverse cholesterol transport (RCT) in 25 endurance-trained male athletes were compared with 33 age-matched males enjoying an active lifestyle. VO2max was higher in athletes than in controls (53.4±1.2 versus 38.8±1.0 mL/min per kg; P<0.01). The following differences in parameters of RCT were found: (1) plasma HDL cholesterol and apoA-I levels were higher in athletes compared with controls (1.7±0.1 versus 1.4±0.1 mmol/L; P<0.001; and 145±2 versus 128±3 mg/dL; P<0.001, respectively). Both correlated with VO2max up to the value of 51 mL/min per kg; (2) pre
1-HDL was higher in athletes than in controls (54±4 versus 37±3 µg/mL; P<0.001) and correlated positively with VO2max; (3) lecithin cholesterol: acyltransferase activity was higher in athletes (29.8±1.2 versus 24.2±1.4 nmol/µL per hour; P<0.005); and (4) the capacity of plasma to promote cholesterol efflux from macrophages was higher in athletes (18.8%±0.8% versus 16.2%±0.3%; P<0.03).
Conclusions--The likely reason for higher HDL concentration in physically fit people is increased formation of HDL from apoA-I and cellular lipids.
This article has been cited by other articles:
![]() |
I. Kralova Lesna, P. Suchanek, J. Kovar, P. Stavek, and R. Poledne Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport J. Lipid Res., November 1, 2008; 49(11): 2414 - 2418. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. M. Ooi, G. F. Watts, P. J. Nestel, D. Sviridov, A. Hoang, and P. H. R. Barrett Dose-Dependent Regulation of High-Density Lipoprotein Metabolism with Rosuvastatin in the Metabolic Syndrome J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 430 - 437. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |